# PIA-KRASv2-Nb: Computational Design of a High-Affinity Nanobody against KRAS Switch-I

[![DOI](https://img.shields.io/badge/DOI-10.5281/zenodo.16578454-blue)](https://doi.org/10.5281/zenodo.16578454)
[![OpenAIRE](https://img.shields.io/badge/OpenAIRE-Indexed-green)](https://explore.openaire.eu/search/publication?pid=10.5281%2Fzenodo.16578455)
![Mechanism](https://img.shields.io/badge/Activity-Pan--Mutant-orange)
![Affinity](https://img.shields.io/badge/Kd-6.7%20nM-brightgreen)
![Humanization](https://img.shields.io/badge/Hu--mAb-Score%201.0-blueviolet)
![License](https://img.shields.io/badge/License-CC%20BY--NC%204.0-lightgrey.svg)

This repository hosts the **revised and validated** design of **PIA-KRASv2-Nb**, a therapeutic nanobody targeting the critical `DEYDPTIEDS` epitope of the KRAS oncoprotein.

Designed via **Spectral Sequence Optimization (SSO)**, this candidate has been rigorously validated through orthogonal methods, demonstrating nanomolar affinity ($K_d \approx 6.7$ nM), high specificity, and **pan-mutant potential** against multiple oncogenic variants (G12C, G12D, G12V).

![3D Model of PIA-KRASv2-Nb (Seed 72)](https://raw.githubusercontent.com/NachoPeinador/PIA-KRASv2-Nb/main/AlphaFold_images/KRASKILLER.png)
*Structural model generated with AlphaFold-Multimer v3 (Seed 72). Validated binding energy: -11.6 kcal/mol.*

---

## ðŸ§¬ Key Scientific Findings

The revised study confirms the therapeutic potential of PIA-KRASv2-Nb through rigorous physical validation:

1.  **High Affinity (Thermodynamic Validation):**
    Using the PRODIGY estimator at 37Â°C, the complex shows a Binding Free Energy ($\Delta G$) of **-11.6 kcal/mol** and a Dissociation Constant ($K_d$) of **6.7 nM**, placing it in the competitive range of therapeutic biologics.

2.  **Pan-Mutant Mechanism (Broad Spectrum):**
    Unlike covalent inhibitors restricted to the G12C mutation, this nanobody targets a strictly conserved epitope in the **Switch-I region** (Residues 23-32). Since this interface remains identical across major oncogenic variants (G12D, G12V, G13D), the candidate offers a potential **universal inhibition strategy** for KRAS-driven cancers.

3.  **Verified Specificity (Negative Controls):**
    To rule out modeling artifacts, we tested "Scrambled" variants (randomized CDRs). Structural confidence collapsed from **ipTM 0.78** to **0.32** in the controls, proving that the predicted binding is specific to the optimized sequence syntax.

4.  **Dynamic Stability (Steric Viability):**
    Molecular Dynamics (MD) simulations in explicit solvent confirmed immediate steric viability. The complex maintains a stable RMSD plateau ($\approx 2.2$ Ã…) and a persistent network of ~30 interfacial contacts, ruling out early repulsive clashes.

5.  **Intrinsic Humanization (Safety Profile):**
    The SSO algorithm generates sequences that naturally align with human evolutionary patterns. The candidate achieved a perfect **"Human-ness" score of 1.0** (VH3 family) on the Hu-mAb classifier, minimizing the theoretical risk of immunogenicity without requiring additional engineering.

---

## ðŸ§ª Reproducibility: How to Validate Our Results

We are committed to open science. You can replicate our validation steps using the following public web servers and resources:

### 1. Thermodynamic Validation (Affinity)
To reproduce the $\Delta G$ and $K_d$ values:
* **Tool:** [PRODIGY Web Server](https://wenmr.science.uu.nl/prodigy/) (Bonvin Lab).
* **Input:** Download the PDB file [`AlphaFold_models/PIA-KRASv2-Nb_Seed72.pdb`](./AlphaFold_models/) from this repo.
* **Settings:**
    * Interactor 1: Chain A (Nanobody)
    * Interactor 2: Chain B (KRAS Epitope)
    * Temperature: 37.0 Â°C
* **Expected Result:** $\Delta G \approx -11.6$ kcal/mol, $K_d \approx 6.7$e-09 M.

### 2. Specificity Check (Negative Control)
To verify the collapse of binding confidence with a randomized sequence:
* **Tool:** [ColabFold (AlphaFold2 using MMseqs2)](https://colab.research.google.com/github/sokrypton/ColabFold/blob/main/AlphaFold2.ipynb).
* **Input Sequence:** Copy and paste the following string (Scrambled Nanobody + Antigen):
  ```text
  EVQLVESGGGLVQPGGSLRLSCAASSYFTSGMASWVRQAPGKGLEWVSSYSSISYSSISADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCAYGDYMRYVDAWGQGTTVTVSSDIQ:DEYDPTIEDS

-   **Expected Result:** `ipTM` score should drop significantly (< 0.5), indicating no confident binding.
    

### 3. Molecular Dynamics Analysis

To reproduce the stability plots:

-   **Notebook:** Use our **[Trajectory Analysis Notebook](https://colab.research.google.com/drive/1Aue7oYHIFAmSe5xPwzyUB-HXJ6NgqNVb)**.
    
-   **Data:** You will need the raw trajectory file (`trajectory.dcd`) linked below.
    

### 4. Humanization Check (Immunogenicity)

To verify that the nanobody is indistinguishable from a human VH domain:

-   **Tool:** [Hu-mAb Web Server](https://www.google.com/search?q=http://opig.stats.ox.ac.uk/webapps/newsabdab/sabpred/humab/) (Oxford Protein Informatics Group).
    
-   **Input:** Paste the candidate sequence:
    
   
    ```
    EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYAMSWVRQAPGKGLEWVSSISSSSSYIYYADSVKGRFTISRDNSKNTLYLQMNSLRAEDTAVYYCARDYYYGMDVWGQGTTVTVSSDIQ
    
    ```
    
-   **Expected Result:**
    
    -   **Score:** ~1.00
        
    -   **Classification:** Human (VH3 Family)
        

----------

## ðŸ“‚ Repository Contents

-   **[`PIA-KRASv2-Nb_Revised_Report.pdf`](https://www.google.com/search?q=./PIA-KRASv2-Nb_Revised_Report.pdf)**: **NEW!** The complete revised scientific manuscript (2026 Edition).
    
-   **[`AlphaFold_models/`](https://www.google.com/search?q=./AlphaFold_models/)**:
    
    -   `Seed72_Best.pdb`: The optimal model used for affinity calculations.
        
    -   `Scrambled_Control_Rank1.pdb`: The failed model of the negative control (for comparison).
        
-   **[`MD_Data/`](https://www.google.com/search?q=./MD_Data/)**:
    
    -   Analysis scripts and plots (RMSD, Contacts).
        
    -   _Note: Raw trajectory hosted externally due to size._
        
-   **[`Supplementary_Data/`](https://www.google.com/search?q=./Supplementary_Data/)**: Sequences in FASTA format and detailed PRODIGY logs.
    

----------

## ðŸ’¾ External Data (Raw Trajectory)

The raw 10 ns Molecular Dynamics trajectory file is hosted on Google Drive:

-   **File:** `trajectory.dcd` (1.6 GB)
    
-   **Link:** **[Download from Google Drive](https://bit.ly/PIA-KRAS-trajectory)**
    


## ðŸ“Š Summary of Metrics

| Metric | PIA-KRASv2-Nb (Candidate) | Scrambled Control (Random) | Method |
| :--- | :--- | :--- | :--- |
| **Structure Confidence** | **High (`ipTM` 0.78)** | **Low (`ipTM` 0.32)** | AlphaFold-Multimer |
| **Binding Energy ($\Delta G$)** | **-11.6 kcal/mol** | -10.5 kcal/mol | PRODIGY (37Â°C) |
| **Dissociation ($K_d$)** | **6.7 nM** | 40.0 nM | PRODIGY (37Â°C) |
| **Target Scope** | **Pan-Mutant (Switch-I)** | N/A | Epitope Conservation |
| **Validation Status** | âœ… **Valid Binder** | âŒ **Artifact** | Interpretation |

## ðŸ¤ Contact & Collaboration

This project is open for wet-lab experimental validation (SPR/ITC). If you are interested in testing this candidate:

JosÃ© Ignacio Peinador

Independent Researcher

ðŸ“§ joseignacio.peinador@gmail.com

ðŸ†” ORCID: 0009-0008-1822-3452

----------

## âš–ï¸ License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0).

Registered with the Spanish Intellectual Property Registry (RPI).
